Vitamins are nutrients which are required in micro grams.They are essential for normal function of the body.They act as cofactors and prosthetic groups for enzymes
this presentation is about Vitamin B6 which include structure , biochemical function , biochemical reaction, effect of deficiency of vitamin B6, Toxicity and function of Vitamin B6.
this presentation is about Vitamin B6 which include structure , biochemical function , biochemical reaction, effect of deficiency of vitamin B6, Toxicity and function of Vitamin B6.
Water soluble vitamin pyridoxine (vitamin B6) introduction, Chemistry of vitamin B6, Biochemical role of vitamin B6, active form of vitamin B 6 (pyridoxal phosphate) synthesis and their role, Recommended dietary allowance of vitamin B6, Dietary sources of vitamin B 6, Deficiency symptoms of Vitamin B6.
Chemistry of vitamin B1, Biochemical functions of vitamin B1, Recommended dietary Allowance of Thiamine, Dietary sources of Thiamine ,Deficiency symptoms of Thiamine
Vitamin B12- Chemistry, functions and clinical significanceNamrata Chhabra
Vitamin B12- Chemical structure, Forms of B12, Sources, absorption, storage, transportation, metabolic role, deficiency, megaloblastic anemia and neurological changes, laboratory diagnosis and treatment
Biotin (vitamin b7) biological functions, clinical indications and its techn...rohini sane
An illustrative presentation on Biotin (Vitamin B7), clinical indications and technological applications for Medical, Dental, Pharmacology & Biotechnology students to facilitate easy- learning.
Water soluble vitamin pyridoxine (vitamin B6) introduction, Chemistry of vitamin B6, Biochemical role of vitamin B6, active form of vitamin B 6 (pyridoxal phosphate) synthesis and their role, Recommended dietary allowance of vitamin B6, Dietary sources of vitamin B 6, Deficiency symptoms of Vitamin B6.
Chemistry of vitamin B1, Biochemical functions of vitamin B1, Recommended dietary Allowance of Thiamine, Dietary sources of Thiamine ,Deficiency symptoms of Thiamine
Vitamin B12- Chemistry, functions and clinical significanceNamrata Chhabra
Vitamin B12- Chemical structure, Forms of B12, Sources, absorption, storage, transportation, metabolic role, deficiency, megaloblastic anemia and neurological changes, laboratory diagnosis and treatment
Biotin (vitamin b7) biological functions, clinical indications and its techn...rohini sane
An illustrative presentation on Biotin (Vitamin B7), clinical indications and technological applications for Medical, Dental, Pharmacology & Biotechnology students to facilitate easy- learning.
HERE PRESENTATING VITAMINS AS PER SYLLABUS OF MPHARM SUBJECT NATURAL PRODUCTS INCLUDING VITAMIN B2, B12, B3, ITS STRUCTURE ISOLATED FROM CONTENTS AND COMPLETE DETAIL ON IT IN A EASY WAY , THE MOST ASKED VITAMINS.
All proteins are formed of 20 amino acids.They are mainly formed of α amino acids (except proline).They have COOH and NH3 on same carbon atom. In physiological conditions both the groups are are completely ionised so an amino acid can act both as acid and base (amphoteric)
Viruses are small, acellular particles that can replicate only in a host cell. They are obligatory intracellular parasites.They
consist of a nucleic acid genome enclosed in a protective protein shell or capsidBacteriophage is the virus that infect bacteria.Bacteriophages were discovered by Frederick Twort(1915)and Felix d'Herelle(1917).
Quality control (QC) is a procedure or set of procedures intended to ensure that a manufactured product or performed service adheres to a defined set of quality criteria or meets the requirements of the client or customer. QC is similar to, but not identical with, quality assurance (QA).
QC IN clinical biochemistry labs and hospitals
Nutrition requirements increases tremendously during pregnancy and lactation as the expectant or nursing mother not only has to nourish herself but also growing foetus and the infant who is being breast fed
A chromosome abnormality, disorder, anomaly, aberration, or mutation is a missing, extra, or irregular portion of chromosomal DNA. It can be from an atypical number of chromosomes or a structural abnormality in one or more chromosomes
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
2. INTRODUCTION
Vitamins are nutrients which are required
in micro grams
They are essential for normal function of
the body
They act as cofactors and prosthetic
groups for enzymes
3. VITAMIN B6
Includes pyridoxal and pyridoxamine.
Pyridoxal phosphate is coenzyme to more
than 100 reaction involving amino acid,
especially transamination and
decarboxylation.
RDA : 1.4 - 2.0 mg/day
4. DISCOVERY OF VITAMIN B6
• It was discovered by Hungarian born scientist
Paul Gyorgy in 1934 who was conducting
research on skin diseases in rats.
• Rat fed on semi synthetic diet (with thiamine
and riboflavin) developed rat acrodynia and it
was cured by Vitamin B6.
• Samuel Lepkovsky isolated and crystallized
Vitamin B6 in 1938.
• In 1939 Leslie Harris, Karl Folker and Richard
Kuhn gave structure.
• Esdmond Snell in 1942 discovered pyridoxamine.
6. PHYSICAL PROPERTIES
• Molecular formula : C8H12NO3
• Molecular weight : 169.17784 g/mol
• 4,5-bis(hydroxymethyl)-2-methyl pyridin-3-ol
• Color : white to crystalline powder
• Taste : bitter taste
• Boiling point : sublime
• Melting point : 159 - 162ᵒ C
• Solubility : 220000 mg/l
• It is photosensitive should be kept between 15 -
30ᵒ C.
8. SOURCES OF VITAMIN B6
• Wheat germ
• Meat
• Potatoes
• Nuts and seeds
• Egg yolks etc.
9. BIOSYNTHESIS
• Made in green plants and microorganisms
from 3 - carbon intermediates of glycolysis
e.g., glyceraldehyde-3-phosphate.
• In E.coli glycerol can furnish all the carbon
atoms.
10. METABOLISM
• In liver ingested pyridoxine is phosphorylated
by specific kinases.
• Then oxidized to pyridoxal phosphate by a
specific flavin enzyme.
• Approximately 90% of B6 administered to
humans is oxidized to 4- pyridoxic acid and is
excreted in this form.
11. FUNCTIONS OF VITAMIN B6
• The conversion of homocysteine to cysteine.
• For energy production from amino acids so
they are also known as energy releasing
vitamins.
• Synthesis of neurotransmitters like serotonin
and norepinephrine.
• Synthesis of sphingolipids required for the
formation of myelin sheath.
12. • Synthesis of delta amino levulinic acid a
precursor of heme.
• Pyridoxal phosphate is also an important
component of glycogen phosphorylase.(It is
covalentaly linked to lysine residue and
stabilise the enzyme)
• To convert tryptophan to nicotinic acid(NAD).
14. DEFICIENCY SYMPTOMS OF VITAMIN
B6
• Low level of vitamin B6 lead to
hyperhomocysteinanemia which is thought
to be a risk factor for ischemic heart disease.(
conversion of homocysteine to cysteine)
• In mild deficiency, symptoms like irritability,
nervousness and depressions arise.(formation of
myelin sheath)
• In severe deficiency, symptoms like
peripheral neuropathy and convulsions arise.
15. • Deficiency cause sideroblastic anemia which
is characteristically a microcytic anemia seen
in presence of high serum iron.(synthesis of heme
precursor)
• Deficiency leads to decrease glucose
tolerance.(as B6 is needed in glycogen phosphorylase and
they also have some direct effect on glucocorticoids)
16. TOXICITY
Vitamin B6 (pyridoxine) causes
neuropathy at intakes of 1000 mg per day
or more, which is about 800 times the
daily intake from foods. There have also
been occasional reports of toxicity at
intakes of 100-300 mg per day.
17. HOW DOES THIS DEFICIENCY ARISE?
• Poor intake, malabsorption or increased
requirement(old age).
• In some infants, when ingesting baby food.
• Intake of contraceptives.
• There is a increased requirement during
pregnancy and lactation.
• Intake of several drugs like isoniazide (as in
TB).
18. HOW IS THE DEFICIENCY DIAGNOSED?
• By activation of red cell amino
transferase by pyridoxine phosphate.
• By measurement of plasma
concentration of pyridoxine phosphate.
• By tryptophan assay.
19. VITAMIN B7 ( BIOTIN )
Co discovered by Dean Burk an American
biochemist.
In 1936 a crystalline growth factor for yeast
was isolated from egg yolk a few years earlier a
factor necessary for the growth and respiration
of Rhizobium had been termed coenzyme R.
Later it was known that both were biotin.
In 1940 biotin was established as anti-egg-
white injury factor.
RDA : 10 micrograms/day
21. PHYSICAL PROPERTIES
• Molecular formula : C10H16N2O35
• Molecular weight : 244.310 g/mol
• Melting point : 232ᵒ C
• Solubility : 220 mg/l (at 25ᵒ C)
• Colorless thin needle like in water
24. BIOSYNTHESIS OF BIOTIN
• Oxidative cleavage of oleic acid
• Addition of Co A
• Removal of acetyl Co A and addition of Co A
• Addition of alanine and removal of carbon
atom
• Transfer of amino group
• Addition of CO2 at expense of energy
• Addition of sulphur atom
25.
26. METABOLISM
• Biocytin (biotinyllysine) is liberated from
biotin holoenzymes by proteolysis.
• Biocytinase in liver and blood liberates biotin
and lysine.
• In mammals biotin sidechains undergoes
usual beta oxidation, yielding 2 moles of
acetyl CoA, the fate of the ring structure is
unknown.
27. FUNCTION
• It is a prosthetic group of many carboxylase
enzymes
• Pyruvate CoA carboxylase needed for synthesis
of OAA for gluconeogenesis and replenishment
of citric acid cycle
• Acetyl CoA carboxylase is needed for fatty acid
biosynthesis
• Propionyl CoA carboxylase is needed for amino
acid metabolism(methionine, leucine and
valine)
28.
29. HOW DOES THE DEFICIENCY ARISE ?
• Egg white contains avidin protein, it binds to
biotin and renders it unavailable for binding
to enzymes. So intake of uncooked egg leads
to deficiency symptoms
• Reduction in intestinal bacteria.
30. TOXICITY
Vitamin B7 (biotin) is not known to be toxic.
However, there is one case report of life-
threatening 'eosinophilic pleuropericardial
effusion' in an elderly woman who took a
combination of 10,000 mcg (= 10 mg)/day
vitamin B7 (biotin) and 300 mg/day vitamin B5
(pantothenic acid) for two months (36)
31. FOLIC ACID
Folic acid (conjugate base folate) is a B vitamin.
Folic acid is made and used in fortified
foods and supplements on the theory that it is
converted into folate. However, folic acid is
an oxidized form, not significantly found in
fresh natural foods. To be used it must be
converted to tetrahydrofolate (tetrahydrofolic
acid) by dihydrofolate reductase (DHFR)
RDA : 50 micrograms/day
32. DISCOVERY OF FOLIC ACID
Folic acid and its role in human biochemical
function was first identified by researcher Lucy
Wills in 1931. She found that this vitamin was
needed to prevent anaemia during pregnancy Dr
Wills demonstrated that anaemia could be
reversed by brewers yeast. It was first extracted by
Mitchell and team in 1941. Bobstokstad isolated
pure crystals.
This led to the synthesis of aminopterin in 1943
first ever anti-cancer drug.
33.
34. PHYSICAL PROPERTIES
• Molecular formula : C19H12N7O6
• Molecular weight : 441.397 g/mol
• Solubility : 1.6 mg/l at 25ᵒC
• Melting point : 250ᵒC
• Colour : orange - yellow needle like crystals
38. METABOLISM
• Folic acid usually occurs as polyglutamate
derivatives .
• These are taken up by mucosal cell and excess
glutamate is removed by conjugase.
• Free folic acid is then reduced to
tetrahydrofolate by enzyme dihyrofolate
reductase and it is circulated as N5– methyl
derivative of tetrahydrofolate.
• Foic acid is stored as polyglutamate derivative of
tetrahydrofolate in liver.
39.
40. FUNCTIONS OF FOLIC ACID
• Derivatives of tetrahydrofolate are used in the
biosynthesis reactions of
• Choline
• Serine
• Glycine
• Purines
• dTMPs
41. DEFICIENCY SYMPTOMS
• Inhibition of DNA synthesis due to lack of
purines and dTMPs.
• This leads to S stage arrest of cell cycle and
formation of ‘megaloblastic’ change in size
and shape of nuclei of rapidly dividing cells.
• During pregnancy it leads to increased
incidence of neural tube defects in foetus.
• Hyperhomocysteinemia occurs leading to
CVD.
42. HOW DEFICIENCY OCCURS ?
• Poor diet, increased requirement.
• Drugs that interfere with folate metabolism.
Example : Methotrexate(folate antagonist),
Cotrimoxazole(inhibit formation of active
tetrahydrofolate).
• In alcoholics poor intake and antagonistic
effect of alcohol is seen.
• Folates are susceptible to oxidation, more
than 50% of folate is destroyed by cooking
43. HOW IS DEFICIENCY DIAGNOSED?
• Folate deficiency is diagnosed by
measurement of serum or red cell folate
content.
• Serum folate content is affected by short
term fluctuations in dietary intake.
• Red cell folate indicates tissue store more
accurately.
44. TOXICITY
There is no health risk associated
with folate intake from food. However, there is
risk of toxicity from folic acid found in dietary
supplements and fortified foods. Folic acid is
used to treat a folate deficiency. However,
a folate deficiency is virtually indistinguishable
from a vitamin B12 deficiency.
45. VITAMIN B12
Vitamin B12 is also known as cyanocobalamine,
Bedoz, cyanoject, cobione.
It is an important vitamin used as a co enzyme
Like in enzymes involved in the synthesis of
methionine from homocysteine and conversion
of methyl malonic acid to succinic acid.
RDA : 2 – 3 microgram/day
47. PHYSICAL PROPERTIES
• Molecular weight : 1356.373117g/mol
• Solubility : 12500mg/l
• Boiling point and melting point is greater
than 300ᵒC
• It is tasteless and odorless
• Dark red crystals or amorphous powder
52. FUNCTIONS OF VITAMIN B12
• It is an important co enzyme for two enzymes
• It help in synthesis of methionine from
homocysteine as it a coenzyme for methionine
synthase
• Methionine is then converted to S -
adenosylmethionine which is methyl donor for
RNA and DNA methylation
• It help in the conversion of methyl malonyl CoA
to succinyl CoA (as it is present in the enzyme L - methyl
malonyl CoA mutase)
55. DEFICIENCY DISEASES
• Causes sub acute combined degeneration of
the spinal cord.
• Cause pernicious anaemia.
• Cause hyper segmentation of neutrophils,
macrocytic anaemia, thrombocytopenia and
megaloblastic changes in bone marrow.
56. REASONS FOR DEFICIENCY
• In pernicious anaemia gastric parietal cells are
destructed by autoantibodies leading to lack in
intrinsic factor.
• Abnormal bacterial flora which inhabits
intestine in case of diseases use excess vitamin
B12.
• Rare infestation with Diphyllobothrium
latum(fish tapeworm).
• Drugs which interfere with B12 metabolism.
• HIV patients develop B12 deficiency due to
malabsorbption.
57. TOXICITY
No toxic or adverse effects have been
associated with large intakes of vitamin
B12from food or supplements in healthy people.
Doses as high as 2 mg (2,000 μg) daily by
mouth or 1 mg monthly by intramuscular (IM)
injection have been used to treat pernicious
anemia without significant side effects
58. REFERENCES
Handbook of Clinical Biochemistry, 2nd edition.
R Swaminathan
- World Scientific Publishing Co. Ltd.
Functional Biochemistry in Health and
Diseases.
Eric Newsholme and Tony Leech
- Wiley Blackwell publication.
http://pubchem.ncbi.nlm.nih.gov/
59. Principles of Biochemistry (Mammalian
Biochemistry) 7th edition
Smith, Hill, Lehman, Lefkowitz, Handler and
White
- McGraw-Hill International Edition
Text book of Biochemistry with clinical
correlations
Thomas M Devlin
Biochemistry
David James and Nigel Hooper